Michelle Schoettler, MD

Research Program

Discovery and Developmental Therapeutics
Phone Number

404-785-1112
Email Address

michelle.long.schoettler@emory.edu

Biography

Michelle L. Schoettler, MD, is a pediatric hematologist at Children's Healthcare of Atlanta and Assistant Professor of Pediatrics in the Emory University School of Medicine. As part of the multidisciplinary team at the Aflac Cancer and Blood Disorders Center, Dr. Schoettler's clinical interest is hematopoietic cellular therapy for hematologic malignancies.

Dr. Schoettler is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute.

Education

Dr. Schoettler completed medical school at Wake Forest University School of Medicine, residency training at Boston Children's Hospital, and hematology/oncology/hematopoietic cellular therapy fellowship at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Titles & Roles

Assistant Professor, Department of Pediatrics

Emory University School of Medicine

Professional Memberships

Dr. Schoettler holds professional memberships with the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Pediatric Hematology and Oncology.

Research

Dr. Schoettler's research focus has been the study of transplant associated thrombotic microangiopathy, a potentially life-threatening complication of hematopoietic cellular therapy. She ultimately aims to improve outcomes for pediatric patients after hematopoietic cellular therapy.

View Current Clinical Trials


Study of Ravulizumab in Pediatric Participants With HSCT-TMA Phase III Conditions Thrombotic Microangiopathy Location Winship Cancer Institute
Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant Phase III Conditions Thrombotic Microangiopathy Location Winship Cancer Institute

Publications

Dr. Schoettler has multiple first author publications and presentations at national meetings describing her work.

Title/Journal	Authors	Publication Date
Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency. British journal of haematology	EL Frost, S Chonat, KM Williams, W Aumann, J Stevenson, J Yin, M Schniederjan, S Arnold, ML Schoettler	12/08/2024
Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients. Transplantation and cellular therapy	G Cheng, MA Smith, R Phelan, R Brazauskas, J Strom, KW Ahn, B Hamilton, A Peterson, B Savani, H Schoemans, M Schoettler, M Sorror, C Higham, S Kharbanda, CC Dvorak, MS Zinter	10/01/2024
Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children. Transplantation and cellular therapy	ML Schoettler, J Ofori, E Bryson, K Spencer, M Qayed, E Stenger, A Bidgoli, S Chonat, A Westbrook, KM Williams	09/01/2024
Application of the Consensus Definition of Transplant Associated Thrombotic Microangiopathy (TA-TMA) Requires a More Expansive Lens to Accurately Diagnose and Risk Stratify Patients-Beware Reliance on Schistocytes Alone. Transplantation and cellular therapy	ML Schoettler, KM Williams	08/01/2024
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-A secondary CIBMTR analysis. British journal of haematology	ML Schoettler, A Westbrook, B Watkins, E Stenger, M Qayed, S Chonat, KM Williams	07/01/2024
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy. Blood advances	ML Schoettler, L Lehmann, PC Kao, N Chen, S Jodele, S Chonat, KM Williams, WB London, C Duncan, C Dandoy	03/12/2024
D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study. American journal of hematology	ML Schoettler, K French, A Harris, E Bryson, L Deeb, Z Hudson, J Obordo, S Chandrakasan, S Parikh, B Watkins, E Stenger, M Qayed, S Chonat, A Westbrook, J Switchenko, KM Williams	03/01/2024
Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children. Transplantation and cellular therapy	ML Schoettler, S Patel, E Bryson, L Deeb, B Watkins, M Qayed, S Chandrakasan, T Fitch, K Silvis, J Jones, S Chonat, KM Williams	03/01/2024
Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes. Frontiers in oncology	MA Smith, G Cheng, R Phelan, R Brazauskas, J Strom, KW Ahn, BK Hamilton, A Peterson, B Savani, H Schoemans, ML Schoettler, M Sorror, RL Keller, CS Higham, CC Dvorak, JR Fineman, MS Zinter	01/01/2024
Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and cellular therapy	PA Patel, MF Teherani, Y Xiang, V Bernardo, S Chandrakasan, KP Goggin, A Haight, E Horwitz, WH Liang, SH Parikh, ML Schoettler, K Spencer, E Stenger, B Watkins, KM Williams, K Leung, P Jaggi, M Qayed	12/01/2023
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis. Bone marrow transplantation	S Raghunandan, L Gorfinkel, B Bratrude, Y Suessmuth, K Hebert, D Neuberg, KM Williams, ML Schoettler, AA Langston, LS Kean, M Qayed, J Horan, BK Watkins	11/01/2023
Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature. Pediatric blood & cancer	C Hughes, A Harris, B Watkins, M Qayed, S Parikh, E Horwitz, E Stenger, KM Williams, ML Schoettler	10/01/2023
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. Blood advances	S Raghunandan, L Gorfinkel, M Graiser, B Bratrude, Y Suessmuth, S Gillespie, AL Westbrook, KM Williams, ML Schoettler, LS Kean, J Horan, AA Langston, M Qayed, B Watkins	08/22/2023
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children. Blood advances	M Schoettler, E Stenger, K Spencer, D Lutterman, S Rumbika, J Jones, A Haight, S Parikh, M Qayed, B Watkins, L Krishnamurti, KM Williams, S Chonat	05/09/2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma. Journal for immunotherapy of cancer	S Raghunandan, M Pauly, WG Blum, M Qayed, MV Dhodapkar, M Elkhalifa, B Watkins, M Schoettler, E Horwitz, S Parikh, S Chandrakasan, K Leung, E Bryson, L Deeb, JL Kaufman, D Worthington-White, A Alazraki, JM Schecter, D Madduri, CC Jackson, E Zudaire, A Taraseviciute-Morris, A Babich, T Nesheiwat, M Vogel, N Lendvai, L Pacaud, KM Williams	05/01/2023
Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality. Frontiers in oncology	ML Schoettler, CE Dandoy, A Harris, M Chan, KM Tarquinio, S Jodele, M Qayed, B Watkins, P Kamat, T Petrillo, J Obordo, CS Higham, CC Dvorak, A Westbrook, MS Zinter, KM Williams	01/01/2023
Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy. Transplantation and cellular therapy	ML Schoettler, BD Saldana, L Berkenkamp, S Chonat, B Watkins, SJ Rotz, D Simons, E Graf, C Rossi, J Cheng, YA Hammers, H Rytting, KM Williams	01/01/2023
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplantation and cellular therapy	GDE Cuvelier, M Schoettler, NP Buxbaum, I Pinal-Fernandez, M Schmalzing, JHW Distler, O Penack, BD Santomasso, R Zeiser, K Angstwurm, KPA MacDonald, WT Kimberly, N Taylor, E Bilic, B Banas, M Buettner-Herold, N Sinha, HT Greinix, J Pidala, KR Schultz, KM Williams, Y Inamoto, C Cutler, LM Griffith, SJ Lee, S Sarantopoulos, SZ Pavletic, D Wolff	08/01/2022
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood advances	S Janardan, E Horwitz, B Watkins, K Williams, S Chandrakasan, M Qayed, S Parikh, S Arnold, F Keller, A Alazraki, M Schoettler, K Leung	05/24/2022
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy. Frontiers in immunology	ML Schoettler, H Bhatt, S Vasu	01/01/2022
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy. Current opinion in hematology	M Schoettler, S Chonat, K Williams, L Lehmann	11/01/2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood advances	CE Dandoy, S Rotz, PB Alonso, A Klunk, C Desmond, J Huber, H Ingraham, C Higham, CC Dvorak, C Duncan, M Schoettler, L Lehmann, M Cancio, J Killinger, B Davila, R Phelan, KM Mahadeo, S Khazal, N Lalefar, M Vissa, K Myers, G Wallace, A Nelson, P Khandelwal, D Bhatla, N Gloude, E Anderson, J Huo, P Roehrs, JJ Auletta, R Chima, A Lane, SM Davies, S Jodele	01/12/2021